Skip to main content
VREX
NASDAQ Manufacturing

Varex Imaging Refinances Debt, Secures $490M Credit Facility, Reduces Annual Interest Expense by Over $7M

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$11.14
Mkt Cap
$452.939M
52W Low
$6.76
52W High
$14.565
52W Position info
65% above low
Off High info
24% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

VREX sits 65% above its 52-week low of $6.76.

Summary

Varex Imaging refinanced its debt, securing a new $490 million credit facility, reducing outstanding debt by $18 million, and is expected to save over $7 million annually in cash interest expenses.


Key Events · Financing and Capital Events · VREX

  • New Credit Facility Secured

    Varex Imaging entered into a new Credit and Guaranty Agreement providing for a $350 million secured term loan facility (drawn), a $100 million secured revolving credit facility, and a $40 million secured delayed draw term loan facility, totaling $490 million in commitments maturing on March 13, 2031.

  • Senior Secured Notes Redeemed

    The company redeemed all $368 million aggregate principal amount of its outstanding 7.875% Senior Secured Notes due 2027, using proceeds from the new term loan and cash on hand.

  • Annual Interest Expense Reduction

    The refinancing is expected to reduce annualized cash interest expense by more than $7 million, reflecting lower interest rates and a net reduction in outstanding debt.

  • Net Debt Reduction

    The transaction resulted in an $18 million net reduction in outstanding debt, contributing to a strengthened balance sheet.


Analysis · VREX · Manufacturing

Varex Imaging Corporation has successfully completed a significant debt refinancing, replacing its existing 7.875% Senior Secured Notes and revolving credit facility with a new, more favorable credit agreement. This strategic move results in a net reduction of $18 million in outstanding debt and is projected to cut annualized cash interest expenses by over $7 million. The new $490 million Credit Facility, comprising a $350 million term loan (already drawn), a $100 million revolving credit facility, and a $40 million delayed draw term loan, significantly strengthens the company's balance sheet and improves its cost of capital. This financial restructuring enhances Varex's flexibility, supports free cash flow generation, and enables continued investment in its core business, building on the company's recent return to net profitability in Q1 FY26.

At the time of this filing, VREX was trading at $11.14 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $452.9M. The 52-week trading range was $6.76 to $14.57. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

VREX - Latest Insights

VREX
May 07, 2026, 4:22 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $11.29
Real-time Price: $11.20 info
Change: -$0.0926 (-0.82%) info
Market Cap: $468.573M info
VREX
May 07, 2026, 4:11 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $11.03
Real-time Price: $11.20 info
Change: +$0.170 (+2%) info
Market Cap: $468.573M info
VREX
May 07, 2026, 4:05 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $11.83
Real-time Price: $11.20 info
Change: -$0.630 (-5%) info
Market Cap: $468.573M info
VREX
Feb 10, 2026, 4:08 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $14.08
Real-time Price: $11.20 info
Change: -$2.88 (-20%) info
Market Cap: $468.573M info
VREX
Feb 10, 2026, 4:06 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $14.08
Real-time Price: $11.20 info
Change: -$2.88 (-20%) info
Market Cap: $468.573M info